On Friday the U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine to be used on people 16 and older in the United States. As the proposed timeline for distribution for the vaccine for adults begins to become clearer, the Centers for Disease Control and Prevention